Sponsor

AJU Pharm Co., Ltd.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name AJU Pharm Co., Ltd. appears in 9 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials9
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

9 shown
Bioequivalence Study of AJU-R713 and R713R in Healthy Adult VolunteersNCT07231861 · lead sponsor · 2025-12-12
COMPLETED
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State StudyNCT07044765 · lead sponsor · 2025-08-01
NOT_YET_RECRUITING
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy AdultsNCT07034781 · lead sponsor · 2025-08-01
NOT_YET_RECRUITING
Efficacy and Safety of AJU-C52 in Essential Hypertension PatientsNCT06416865 · lead sponsor · 2022-10-18
COMPLETED
A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy VolunteersNCT05077475 · lead sponsor · 2021-09-24
UNKNOWN
A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy VolunteersNCT05077462 · lead sponsor · 2021-09-17
UNKNOWN
Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus PatientsNCT06329674 · lead sponsor · 2021-04-27
COMPLETED
Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy AdultsNCT04972539 · lead sponsor · 2020-08-01
COMPLETED
The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2NCT04970940 · lead sponsor · 2020-07-02
COMPLETED

Sponsor roles

lead sponsor9
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.